125 related articles for article (PubMed ID: 14555301)
21. Effects of a Helicobacter pylori eradication regimen on anti-platelet autoantibody response in infected and uninfected patients with idiopathic thrombocytopenic purpura.
Asahi A; Kuwana M; Suzuki H; Hibi T; Kawakami Y; Ikeda Y
Haematologica; 2006 Oct; 91(10):1436-7. PubMed ID: 16963398
[TBL] [Abstract][Full Text] [Related]
22. Effect of lansoprazole for an idiopathic thrombocytopenic purpura patient with Helicobacter pylori infection who did not respond to prednisolone treatment.
Tsutsumi Y; Kanamori H; Yamato H; Ehira N; Miura T; Kawamura T; Obara S; Tanaka J; Asaka M; Imamura M; Masauzi N
Clin Lab Haematol; 2004 Oct; 26(5):363-4. PubMed ID: 15485469
[No Abstract] [Full Text] [Related]
23. High prevalence of sustained remission of idiopathic thrombocytopenic purpura after Helicobacter pylori eradication: a long-term follow-up study.
Veneri D; Krampera M; Franchini M
Platelets; 2005 Mar; 16(2):117-9. PubMed ID: 15823868
[TBL] [Abstract][Full Text] [Related]
24. Analysis of B- and T-cell clonality and HLA class II alleles in patients with idiopathic thrombocytopenic purpura: correlation with Helicobacter pylori infection and response to eradication treatment.
Veneri D; De Matteis G; Solero P; Federici F; Zanuso C; Guizzardi E; Arena S; Gaio M; Pontiero P; Ricetti MM; Franchini M
Platelets; 2005 Aug; 16(5):307-11. PubMed ID: 16011982
[TBL] [Abstract][Full Text] [Related]
25. Immune thrombocytopenic purpura and Helicobacter pylori infection.
Morselli M; Potenza L; Luppi M; Torelli G; Emilia G
Arch Intern Med; 2003 Jan; 163(1):120; authors reply 120-1. PubMed ID: 12523929
[No Abstract] [Full Text] [Related]
26. Infectious agents and human immune diseases: Lessons from Helicobacter pylori.
Emilia G; Luppi M; Torelli G
Am J Med; 2005 Apr; 118(4):420-1. PubMed ID: 15808141
[No Abstract] [Full Text] [Related]
27. Helicobacter pylori eradication reduces platelet count in patients without idiopathic thrombocytopenic purpura.
Matsukawa Y; Kato K; Hatta Y; Iwamoto M; Mizuno S; Kurihara R; Arakawa Y; Kurosaka H; Hayashi I; Sawada S
Platelets; 2007 Feb; 18(1):52-5. PubMed ID: 17365854
[TBL] [Abstract][Full Text] [Related]
28. Successful treatment of secondary Helicobacter pylori eradication for chronic immune thrombocytopenic purpura.
Kobayashi Y; Hatta Y; Uchino Y
Platelets; 2014; 25(8):645. PubMed ID: 24205803
[No Abstract] [Full Text] [Related]
29. Extragastric manifestations of Helicobacter pylori infection--other Helicobacter species.
Solnick JV; Franceschi F; Roccarina D; Gasbarrini A
Helicobacter; 2006 Oct; 11 Suppl 1():46-51. PubMed ID: 16925612
[TBL] [Abstract][Full Text] [Related]
30. Relationships among HLA-DRB1 Alleles, Helicobacter pylori infection and idiopathic thrombocytopenic purpura in children.
Li X; Sheng G; Xing H
Minerva Pediatr; 2015 Aug; 67(4):377-9. PubMed ID: 26129806
[No Abstract] [Full Text] [Related]
31. The long-term efficacy of Helicobacter pylori eradication therapy in patients with idiopathic thrombocytopenic purpura.
Satake M; Nishikawa J; Fukagawa Y; Akashi K; Okamoto T; Yoshida T; Hirano A; Maetani N; Iida Y; Sakaida I
J Gastroenterol Hepatol; 2007 Dec; 22(12):2233-7. PubMed ID: 17559384
[TBL] [Abstract][Full Text] [Related]
32. Does Helicobacter pylori eradication play a role in immune thrombocytopenia?
Llovet V; Rada G
Medwave; 2016 Sep; 16 Suppl 3():e6528. PubMed ID: 27603101
[TBL] [Abstract][Full Text] [Related]
33. The effects of Helicobacter pylori eradication on chemokine production in patients with immune thrombocytopenic purpura.
Nomura S; Inami N; Kanazawa S
Eur J Haematol; 2004 Apr; 72(4):304-5. PubMed ID: 15089773
[No Abstract] [Full Text] [Related]
34. Helicobacter pylori infection and childhood idiopathic thrombocytopenic purpura.
Wu KS; Hsiao CC; Yu HR; Huang EY; Mai WL; Sheen JM
Acta Paediatr Taiwan; 2007; 48(5):263-6. PubMed ID: 18254575
[TBL] [Abstract][Full Text] [Related]
35. Is induction of platelet recovery related to correction of cobalamin deficiency due to Helicobacter pylori eradication in ITP?
Kaptan K; Beyan C
Am J Hematol; 2005 Oct; 80(2):168. PubMed ID: 16184586
[No Abstract] [Full Text] [Related]
36. [Usefulness of the eradication of Helicobacter pylori for the patient with idiopathic thrombocytopenic purpura and lung cancer: report of a case].
Kita Y; Nogimura H; Hasegawa H; Kato M; Ozawa Y; Yasuda S; Nishihara K; Suzuki K; Kazui T
Kyobu Geka; 2005 Jun; 58(6):509-11. PubMed ID: 15957429
[TBL] [Abstract][Full Text] [Related]
37. Successful treatment of primary immune thrombocytopenia in aged patients using clarithromycin.
Ohe M; Hashino S
J Formos Med Assoc; 2014 Mar; 113(3):197-8. PubMed ID: 24630039
[No Abstract] [Full Text] [Related]
38. Platelet response to Helicobacter pylori eradication therapy in adult chronic idiopathic thrombocytopenic purpura seems to be related to the presence of anticytotoxin-associated gene A antibodies.
Scandellari R; Allemand E; Vettore S; Plebani M; Randi ML; Fabris F
Blood Coagul Fibrinolysis; 2009 Mar; 20(2):108-13. PubMed ID: 19786938
[TBL] [Abstract][Full Text] [Related]
39. The relationship between immune thrombocytopenic purpura and Helicobacter pylori infection in children: where is the truth?
Loffredo G; Marzano MG; Migliorati R; Miele E; Menna F; Poggi V; Staiano A
Eur J Pediatr; 2007 Oct; 166(10):1067-8. PubMed ID: 17136353
[No Abstract] [Full Text] [Related]
40. Proof of an association between Helicobacter pylori and idiopathic thrombocytopenic purpura in Latin America.
Campuzano-Maya G
Helicobacter; 2007 Jun; 12(3):265-73. PubMed ID: 17493008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
